LAUNCH EFFECT

Formula

The premium mood enhancer formula

We’ve specially prepared this mix of vitamins and minerals to optimize your mental acuity, physical readiness and emotional wellbeing. We’ve included mulitiple articles on the specific Ingredients.

Order your risk-free supply of Sera here

Ingredients

IngredientsAmountCost at GNC
IngredientsAmountCost at GNC
Vitamin C50 MG11.99
Vitamin D3500 IU4.99
Vitamin B650 MG14.99*
Folic Acid800 mcg6.99
Vitamin B12800 mcg*
Inositol500 MG11.99
Chromium200 mcg9.99
Selenium100 mcg4.99
Zinc10 MG3.99
Magnesium125 MG4.99
Niacin500 MG9.99
Calcium250 MG6.99
TotalSera was $49.99 now $29.99$91.89

 

After reading our ingredients you’ll agree that Sera is the right mood enhancer for you. Order your bottle now

References

REFERENCES:
http://momswellness.wordpress.com/2009/05/17/data-on-magnesium-and-mood-2/
http://www.nutritional-healing.com.au/content/articles-content.php?headi
Banki CM, Arato M, Kilts CD. Aminergic studies and cerebrospinal fluid cations in suicide. Ann N Y Acad Sci. 1986;487:221-30.
Banki CM, Vojnik M, Papp Z, Balla KZ, Arato M. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry. 1985 Feb;20(2):163-71.
Cade JF. A Significant Elevation of Plasma Magnesium Levels in Schizophrenia and Depressive States. Med J Aust. 1964 Feb 8;10:195-6.
Chouinard, G., Beauclair, L., Geiser, R., & Etienne, P. (1990). A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Progress in Neuropsychopharmacology Biology and Psychiatry, 14, 171–180.
Freyre AV, Flichman JC. Spasmophilia caused by magnesium deficit. Psychosomatics. 1970 Sep-Oct;11(5):500-1.
Frizel D, Coppen A, Marks V. Plasma magnesium and calcium in depression. Br J Psychiatry. 1969 Dec;115(529):1375-7.
Frizel D, et al. Plasma magnesium and calcium in depression. Br J Psychiatry 1969;115:1375-7.

Hasey GM, D’Alessandro E, Cooke RG, Warsh JJ. The interface between thyroid activity, magnesium, and depression: a pilot study. Biol Psychiatry. 1993 Jan 15;33(2):133-5.
Heiden, A., Frey, R., Presslich, O., Blasbichler, T., Smetana, R., & Kasper,S. (1999). Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy. Psychiatry Research, 89, 239–246.
Heseker H, Kubler W, Pudel V, Westenhoffer J. Psychological disorders as early symptoms of a mild-to-moderate vitamin deficiency. Ann N Y Acad Sci. 1992 Sep 30;669:352-7.
Kamei K, Tabata O, Muneoka K, Muraoka SI, Tomiyoshi R, Takigawa M. Electrolytes in erythrocytes of patients with depressive disorders. Psychiatry Clin Neurosci. 1998 Oct;52(5):529-33.
Kaplan, B., Crawford, S., Field, C., Simpson, J. S., (2007) Vitamins, Minerals and Mood. American Psychological Association-Psych Bulletin, Vol. 133, No. 5, 747-760.Kirov, G. K., & Tsachev, K. N. (1990). Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology, 23, 79–81.
Kirov GK, Birch NJ, Steadman P, Ramsey RG. Plasma magnesium levels in a population of psychiatric patients: correlations with symptoms. Neuropsychobiology. 1994;30(2-3):73-8.
Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology. 1990;23(2):79-81.
Leitner ZA, Church IC. Nutritional studies in a mental hospital. Lancet. 1956 Apr 28;270(6922):565-7.
Levine J, Stein D, Rapoport A, Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology. 1999;39(2):63-70.
Mann J & Truswell AS. Essentials of Human Nutrition. 2nd edition. New York: Oxford University Press; 2002.
Manser WW, Khan MA, Hasan KZ. Trace element studies on Karachi population. Part IV: Blood copper, zinc, magnesium and lead levels in psychiatric patients with depression, mental retardation and seizure disorders. J Pak Med Assoc. 1989 Oct;39(10):269-74.
McCoy MA, Young PB, Hudson AJ, Davison G, Kennedy DG. Regional brain monoamine concentrations and their alterations in bovine hypomagnesaemic tetany experimentally induced by a magnesium-deficient diet. Res Vet Sci. 2000 Dec;69(3):301-7.
RA Buist. Anxiety neurosis: The lactate connection. Int Clin Nutr Rev, 5(1):1-4, 1985
Rasmussen HH, Mortensen PB, Jensen IW. Depression and magnesium deficiency. Int J Psychiatry Med. 1989;19(1):57-63.
Rivlin RS. Riboflavin. In: Ziegler EE, Filer LJ, eds. Present Knowledge in Nutrition. 7th ed. Washington D.C.: ILSI Press; 1996:167-173.
Seelig MS. Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review). J Am Coll Nutr. 1994 Oct;13(5):429-46.
Shealy CN, et al. Magnesium deficiency in depression and chronic pain. Magnesium Trace Elem 1990;9:333.
Shils ME. Magnesium. In: Shils M, Olson JA, Shike M, Ross AC, eds. Nutrition in Health and Disease. 9th ed. Baltimore: Williams & Wilkins; 1999:169-192.
Siwek M, Wrobel A, Dudek D, Nowak G, Zieba A. The role of copper and magnesium in the pathogenesis and treatment of affective disorders. Psychiatr Pol. 2005 Sep-Oct;39(5):911-20.
Wacker WE, Parisi AF. Magnesium metabolism. N Engl J Med. 1968 Apr 4;278(14):772-6 concl.
Widmer J, Bovier P, Karege F, Raffin Y, Hilleret H, Gaillard JM, Tissot R. Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months. Neuropsychobiology. 1992;26(4):173-9.
Young SN, Ghadirian AM. Folic acid and psychopathology. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(6):841-63.
Adams PW, et al. Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraceptives. Lancet 1973;1:897-904.
Banki CM, Arato M, Kilts CD. Aminergic studies and cerebrospinal fluid cations in suicide. Ann N Y Acad Sci. 1986;487:221-30.
Banki CM, Vojnik M, Papp Z, Balla KZ, Arato M. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry. 1985 Feb;20(2):163-71.
Bell IR, Edman JS, Marby DW, Satlin A, Dreier T, Liptzin B, Cole JO. Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biol Psychiatry. 1990 Jan 15;27(2):125-37.
Bell IR, Edman JS, Miller J, Hebben N, Linn RT, Ray D, Kayne HL. Relationship of normal serum vitamin B12 and folate levels to cognitive test performance in subtypes of geriatric major depression. J Geriatr Psychiatry Neurol. 1990 Apr-Jun;3(2):98-105.
Bell IR, Edman JS, Morrow FD, Marby DW, Mirages S, Perrone G, Kayne HL, Cole JO. B complex vitamin patterns in geriatric and young adult inpatients with major depression. J Am Geriatr Soc. 1991 Mar;39(3):252-7.
Benton D, Haller J, Fordy J. Vitamin supplementation for 1 year improves mood. Neuropsychobiology. 1995;32(2):98-105.
Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord. 2001 Apr;64(1):43-51.
Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry. 2003 Jun;60(6):618-26.
Bottiglieri T, Hyland K, Laundy M, Godfrey P, Carney MW, Toone BK, Reynolds EH. Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med. 1992 Nov;22(4):871-6.
Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev. 1996 Dec;54(12):382-90.
Cade JF. A Significant Elevation of Plasma Magnesium Levels in Schizophrenia and Depressive States. Med J Aust. 1964 Feb 8;10:195-6.
Carney MW, Chary TK, Laundy M, Bottiglieri T, Chanarin I, Reynolds EH, Toone B. Red cell folate concentrations in psychiatric patients. J Affect Disord. 1990 Jul;19(3):207-13.
Carney MW, Sheffield BF. Associations of subnormal serum folate and vitamin B12 values and effects of replacement therapy. J Nerv Ment Dis. 1970 May;150(5):404-12.
Carney MW, Sheffield BF. Serum folic acid and B12 in 272 psychiatric in-patients. Psychol Med. 1978 Feb;8(1):139-44.
Carney MW. Serum folate values in 423 psychiatric patients. Br Med J. 1967 Dec 2;4(578):512-6
Connor DJ. Thiamine intake and monoamine oxidase activity. Biol Psychiatry. 1981 Sep;16(9):869-72.
Cooper JR. The role of ascorbic acid in the oxidation of tryptophan to 5-hydroxytryptophan. Ann NY Acad Sci 1961;92:208-11.
Durand C, Mary S, Brazo P, Dollfus S. Psychiatric manifestations of vitamin B12 deficiency: a case report. Encephale. 2003 Nov-Dec;29(6):560-5.
Edeh J, Toon BK. A general practice study of the prevalence of psychiatric morbidity and social handicap in epilepsy, in M Parsonage et al, Eds. Advances in Epileptology. XV Epilepsy International Symposium. New York, Raven Press, 1983.
Edwin E, Holten K, Norum Kr, Schrumpf A, Skaug OE. Vitamin B12 Hypovitaminosis in Mental Diseases. Acta Med Scand. 1965 Jun;177:689-99.
Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry. 1997 Mar;154(3):426-8.
Freyre AV, Flichman JC. Spasmophilia caused by magnesium deficit. Psychosomatics. 1970 Sep-Oct;11(5):500-1.
Frizel D, Coppen A, Marks V. Plasma magnesium and calcium in depression. Br J Psychiatry. 1969 Dec;115(529):1375-7.
Frizel D, et al. Plasma magnesium and calcium in depression. Br J Psychiatry 1969;115:1375-7.
G Milner. Ascorbic acid in chronic psychiatric patients: a controlled trial. Br J Psychiatry 1963;109:294-9.
Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. 1990 Aug 18;336(8712):392-5.
Goodman KI, Salt WB 2nd. Vitamin B12 deficiency. Important new concepts in recognition. Postgrad Med. 1990 Sep 1;88(3):147-50, 153-8.
H. Wick, K. Schweizer, R. Baumgartner. Thiamine dependency in a patient with congenital lacticacidaemia due to pyruvate dehydrogenase deficiency. Inflammation Research. Volume 7, Number 3 / September, 1977.
Hallstrom T. Serum B12 and folate concentrations in mental patients. Acta Psychiatr Scand. 1969;45(1):19-36.
Hasey GM, D’Alessandro E, Cooke RG, Warsh JJ. The interface between thyroid activity, magnesium, and depression: a pilot study. Biol Psychiatry. 1993 Jan 15;33(2):133-5.
Hawkins WW, Barsky J. An experiment on human vitamin B6 deprivation. Science 1948;108:284-6.
Hector M, Burton JR. What are the psychiatric manifestations of vitamin B12 deficiency? J Am Geriatr Soc. 1988 Dec;36(12):1105-12.
Heseker H, Kubler W, Pudel V, Westenhoffer J. Psychological disorders as early symptoms of a mild-to-moderate vitamin deficiency. Ann N Y Acad Sci. 1992 Sep 30;669:352-7.
Hickie I, Naismith S, Ward PB, Scott E, Mitchell P, Wilhelm K, Parker G. Vascular risk and low serum B12 predict white matter lesions in patients with major depression. J Affect Disord. 2005 Apr;85(3):327-32.
Hintikka J, Tolmunen T, Tanskanen A, Viinamaki H. High vitamin B12 level and good treatment outcome may be associated in major depressive disorder. BMC Psychiatry. 2003 Dec 2;3:17.
Holmes JM. Cerebral manifestations of vitamin-B12 deficiency. Br Med J. 1956 Dec 15;(5006):1394-8.
Howard JS 3rd. Folate deficiency in psychiatric practice. Psychosomatics. 1975;16(3):112-5.
Hvas AM, Juul S, Bech P, Nexo E. Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom. 2004 Nov-Dec;73(6):340-3.
J Broek, H Guetzkow. Psychologic Effects of Thiamine Restriction and Deprivation in Normal Young Men. American Journal of Clinical Nutrition, 1957.
JE Alpert, M Fava. Nutrition and depression: the role of folate. Nutr Rev 55(5):145-9, 1997
Kamei K, Tabata O, Muneoka K, Muraoka SI, Tomiyoshi R, Takigawa M. Electrolytes in erythrocytes of patients with depressive disorders. Psychiatry Clin Neurosci. 1998 Oct;52(5):529-33.
Kaufman S. Coenzymes and hydroxylases: ascorbate and dopamine-beta-hydroxylase; tetrahydropteridines and phenylalanine and tyrosine hydroxylases. Pharmacol Rev. 1966 Mar;18(1):61-9.
Kinsman RA, Hood J. Some behavioral effects of ascorbic acid deficiency. American Journal of Clinical Nutrition, Vol 24, 455-464, 1971.
Kirov GK, Birch NJ, Steadman P, Ramsey RG. Plasma magnesium levels in a population of psychiatric patients: correlations with symptoms. Neuropsychobiology. 1994;30(2-3):73-8.
Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology. 1990;23(2):79-81.
LC Abbey. Agoraphobia. J Orthomol Psychiatry, 11:243-59, 1982
Lee S, Wing YK, Fong S. A controlled study of folate levels in Chinese inpatients with major depression in Hong Kong. J Affect Disord. 1998 Apr;49(1):73-7.
Leitner ZA, Church IC. Nutritional studies in a mental hospital. Lancet. 1956 Apr 28;270(6922):565-7.
Leklem JE. Vitamin B-6. In: Machlin L, ed. Handbook of Vitamins. New York: Marcel Decker Inc; 1991:341-378.
Lerner V, Kanevsky M, Dwolatzky T, Rouach T, Kamin R, Miodownik C. Vitamin B12 and folate serum levels in newly admitted psychiatric patients. Clin Nutr. 2006 Feb;25(1):60-7.
Levine J, Stein D, Rapoport A, Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology. 1999;39(2):63-70.
Levitt AJ, Joffe RT. Folate, B12 and thyroid function in depression. Biol Psychiatry. 1993 Jan 1;33(1):52-3.
Levitt AJ, Joffe RT. Folate, B12, and life course of depressive illness. Biol Psychiatry. 1989 Apr 1;25(7):867-72.
Little KY, Castellanos X, Humphries LL, Austin J. Altered zinc metabolism in mood disorder patients. Biol Psychiatry. 1989 Oct;26(6):646-8.
M Fava, JS Borus, JE Alpert, AA Nierenberg, JF Rosenbaum and T Bottiglieri. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997; 154:426-428
Maes M, De Vos N, Demedts P, Wauters A, Neels H. Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J Affect Disord. 1999 Dec;56(2-3):189-94.
Maes M, D’Haese PC, Scharpe S, D’Hondt P, Cosyns P, De Broe ME. Hypozincemia in depression. J Affect Disord. 1994 Jun;31(2):135-40.
Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry. 1997 Sep 1;42(5):349-58.
Mann J & Truswell AS. Essentials of Human Nutrition. 2nd edition. New York: Oxford University Press; 2002.
Manser WW, Khan MA, Hasan KZ. Trace element studies on Karachi population. Part IV: Blood copper, zinc, magnesium and lead levels in psychiatric patients with depression, mental retardation and seizure disorders. J Pak Med Assoc. 1989 Oct;39(10):269-74.
McCoy MA, Young PB, Hudson AJ, Davison G, Kennedy DG. Regional brain monoamine concentrations and their alterations in bovine hypomagnesaemic tetany experimentally induced by a magnesium-deficient diet. Res Vet Sci. 2000 Dec;69(3):301-7.
McLoughlin IJ, Hodge JS. Zinc in depressive disorder. Acta Psychiatr Scand. 1990 Dec;82(6):451-3.
Mischoulon D, Burger JK, Spillmann MK, Worthington JJ, Fava M, Alpert JE. Anemia and macrocytosis in the prediction of serum folate and vitamin B12 status, and treatment outcome in major depression. J Psychosom Res. 2000 Sep;49(3):183-7.
Murray A, Raul RS, Enrique RP. Prediction of Treatment Response in Geriatric Depression From Baseline Folate Level: Interaction With an SSRI or a Tricyclic Antidepressant. Journal of Clinical Psychopharmacology. 23(3):309-313, June 2003.
MW Carney, A Ravindran, MG Rinsler and DG Williams. Thiamine, riboflavin and pyridoxine deficiency in psychiatric in- patients. The British Journal of Psychiatry 141: 271-272 (1982)
MW Carney, DG Williams and BF Sheffield. Thiamine and pyridoxine lack newly-admitted psychiatric patients. The British Journal of Psychiatry 135: 249-254 (1979)
Narang RL, Gupta KR, Narang AP, Singh R. Levels of copper and zinc in depression. Indian J Physiol Pharmacol. 1991 Oct;35(4):272-4.
Nowak G, Szewczyk B, Pilc A. Zinc and depression. An update. Pharmacol Rep. 2005 Nov-Dec;57(6):713-8.
Nowak G, Szewczyk B, Sadlik K, Piekoszewski W, Trela F, Florek E, Pilc A. Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims. Pol J Pharmacol. 2003 May-Jun;55(3):455-9.
Nowak G, Zieba A, Dudek D, Schlegel-Zawadzka M, Pilc A. Zinc homeostasis and glutamatergic system in the pathogenesis and treatment of depression. Psychiatr Pol. 2001 Mar-Apr;35(2):257-66.
Nowak G. Alterations in zinc homeostasis in depression and antidepressant therapy. Pol J Pharmacol. 1998 Jan-Feb;50(1):1-4.
O’Dell BL. Role of zinc in plasma membrane function. J Nutr. 2000;130(5S Suppl):1432S-1436S.
Papakostas GI, Petersen T, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry. 2004 Aug;65(8):1090-5.
Powers HJ. Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine. Proc Nutr Soc. 1999;58(2):435-440.
RA Buist. Anxiety neurosis: The lactate connection. Int Clin Nutr Rev, 5(1):1-4, 1985
Ramsey TA, Frazer A, Mendels J. Plasma and erythrocyte cations in affective illness. Neuropsychobiology. 1979;5(1):1-10.
Rasmussen HH, Mortensen PB, Jensen IW. Depression and magnesium deficiency. Int J Psychiatry Med. 1989;19(1):57-63.
Ray T. Sterner and Wayne R. Price. Restricted riboflavin: within-subject behavioral effects in humans. American Journal of Clinical Nutrition, Vol 26, 150-160, 1973
RD Williams, HL Mason, MH Power, RM Wilder. Induced thiamine (vitamin B1) deficiency in man; relation of depletion of thiamine to development of biochemical defect and of polyneuropathy. Arch Int Med. 71:38-53, 1943.
Reynolds EH, Preece JM, Bailey J, Coppen A. Folate deficiency in depressive illness. Br J Psychiatry. 1970 Sep;117(538):287-92.
Rivlin RS. Riboflavin. In: Ziegler EE, Filer LJ, eds. Present Knowledge in Nutrition. 7th ed. Washington D.C.: ILSI Press; 1996:167-173.
Robert E. Hodges, James Hood, John E. Canham, Howerde E. Sauberlich, and Eugene M. Baker. Clinical manifestations of ascorbic acid deficiency in man. American Journal of Clinical Nutrition, Vol 24, 432-443, 1971.
Russ CS. Vitamin B6 status of depressed and obsessive-compulsive patients. Nutr Rep Int 1983;27:867-873.
Rybakowski J, Jankowiak E. Plasma and erythrocyte electrolytes in endogenous depression –neurophysiologic implications. Psychiatr Pol. 1989 Jul-Aug;23(4):265-70.
Sachdev PS, Parslow RA, Lux O, Salonikas C, Wen W, Naidoo D, Christensen H, Jorm AF. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol Med. 2005 Apr;35(4):529-38
Schorah CJ, Morgan DB, Hullin RP. Plasma vitamin C concentrations in patients in a psychiatric hospital. Hum Nutr Clin Nutr. 1983 Dec;37(6):447-52.
Seelig MS. Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review). J Am Coll Nutr. 1994 Oct;13(5):429-46.
Shealy CN, et al. Magnesium deficiency in depression and chronic pain. Magnesium Trace Elem 1990;9:333.
Shils ME. Magnesium. In: Shils M, Olson JA, Shike M, Ross AC, eds. Nutrition in Health and Disease. 9th ed. Baltimore: Williams & Wilkins; 1999:169-192.
Shorvon SD, Carney MW, Chanarin I, Reynolds EH. The neuropsychiatry of megaloblastic anaemia. Br Med J. 1980 Oct 18;281(6247):1036-8.
Singh RB, Ghosh S, Niaz MA, Singh R, Beegum R, Chibo H, Shoumin Z, Postiglione A. Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol. 1995 Dec 15;76(17):1233-8.
Siwek M, Wrobel A, Dudek D, Nowak G, Zieba A. The role of copper and magnesium in the pathogenesis and treatment of affective disorders. Psychiatr Pol. 2005 Sep-Oct;39(5):911-20.
Stewart JW, Harrison W, Quitkin F, Baker H. Low B6 levels in depressed outpatients. Biol Psychiatry. 1984 Apr;19(4):613-6.
T Bottiglieria, M Laundya, R Crellinb, BK Tooneb, MWP Carneyc, EH Reynoldsa. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000;69:228-232
Tolmunen T, Hintikka J, Ruusunen A, Voutilainen S, Tanskanen A, Valkonen VP, Viinamaki H, Kaplan GA, Salonen JT. Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother Psychosom. 2004 Nov-Dec;73(6):334-9.
Wacker WE, Parisi AF. Magnesium metabolism. N Engl J Med. 1968 Apr 4;278(14):772-6 concl.
Wada L, King JC. Effect of low zinc intakes on basal metabolic rate, thyroid hormones and protein utilization in adult men. J Nutr. 1986 Jun;116(6):1045-53.
Widmer J, Bovier P, Karege F, Raffin Y, Hilleret H, Gaillard JM, Tissot R. Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months. Neuropsychobiology. 1992;26(4):173-9.
Wilkinson AM, Anderson DN, Abou-Saleh MT, Wesson M, Blair JA, Farrar G, Leeming RJ. 5-Methyltetrahydrofolate level in the serum of depressed subjects and its relationship to the outcome of ECT. J Affect Disord. 1994 Nov;32(3):163-8.
Wolfersdorf M, Maier V, Froscher W, Laage M, Straub R. Folic acid deficiency in patients hospitalized with depression? A pilot study of clinical relevance. Nervenarzt. 1993 Apr;64(4):269-72.
Young SN, Ghadirian AM. Folic acid and psychopathology. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(6):841-63.
Zieba A, Kata R, Dudek D, Schlegel-Zawadzka M, Nowak G. Serum trace elements in animal models and human depression: Part III. Magnesium. Relationship with copper. Hum Psychopharmacol. 2000 Dec;15(8):631-635.

×

privacy policy.

Your email will never be shared with a third party. We'll only use it to notify you of our launch and of special events taking place in your city. You'll have the opportunity to unsubscribe at any time, immediately, once you receive your first email.